Tag: Neurotech International ASX: NTI

Neurotech International to Kickstart Clinical Trial of NTI164 Post HREC Approval

Interesting Reads, News, SLIDER, Trending News

Neurotech International (ASX: NTI) has secured authorization to commence a notable Phase I/II clinical trial of its proprietary...
Read More Read More: Neurotech International to Kickstart Clinical Trial of NTI164 Post HREC Approval
Close Search Window
Close